Literature DB >> 26239490

Dysregulation of FMRP/mTOR Signaling Cascade in Hypoxic-Ischemic Injury of Premature Human Brain.

Mirna Lechpammer1, Pia Wintermark2, Katherine M Merry3, Michele C Jackson3, Lauren L Jantzie4, Frances E Jensen5.   

Abstract

In this study the authors investigated whether dysregulation of the fragile X mental retardation protein and mammalian target of rapamycin signaling cascade can have a role in the pathogenesis of encephalopathy of prematurity following perinatal hypoxia-ischemia. The authors examined the brain tissue of newborns with encephalopathy and compared it to age-matched controls with normal brain development and adults. In normal controls, the fragile X mental retardation protein expression in cortical gray matter spiked 4-fold during 36-39 gestational weeks compared to the adult, with a concomitant suppression of p70S6K and S6. In encephalopathy cases, the developmental spike of fragile X mental retardation protein was not observed, and fragile X mental retardation protein levels remained significantly lower than in normal controls. Importantly, this fragile X mental retardation protein downregulation was followed by a significant overexpression of p70S6K and S6. These novel findings thus suggest that premature hypoxic-ischemic brain injury can affect the fragile X mental retardation protein/mammalian target of rapamycin pathway, as otherwise observed in inherited syndromes of cognitive disability and autism spectrum disorders.
© The Author(s) 2015.

Entities:  

Keywords:  autism; brain injury; fragile X mental retardation protein; hypoxia; mammalian target of rapamycin; prematurity

Mesh:

Substances:

Year:  2015        PMID: 26239490      PMCID: PMC4740274          DOI: 10.1177/0883073815596617

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  21 in total

1.  Developmental regulation of group I metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia.

Authors:  Lauren L Jantzie; Delia M Talos; Debra B Selip; Li An; Michele C Jackson; Rebecca D Folkerth; Wenbin Deng; Frances E Jensen
Journal:  Neuron Glia Biol       Date:  2011-12-14

Review 2.  Role of glutamate receptors in periventricular leukomalacia.

Authors:  Frances E Jensen
Journal:  J Child Neurol       Date:  2005-12       Impact factor: 1.987

Review 3.  Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome.

Authors:  Gül Dölen; Mark F Bear
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

4.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

Review 5.  Phenotypic variation and FMRP levels in fragile X.

Authors:  Danuta Z Loesch; Richard M Huggins; Randi J Hagerman
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

Review 6.  Late preterm infants: near term but still in a critical developmental time period.

Authors:  Amir Kugelman; Andrew A Colin
Journal:  Pediatrics       Date:  2013-09-23       Impact factor: 7.124

7.  Pathology of inherited manganese transporter deficiency.

Authors:  Mirna Lechpammer; Michael S Clegg; Zukhrofi Muzar; Philip A Huebner; Lee-Way Jin; Sidney M Gospe
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

8.  Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

Authors:  Pamela L Follett; Wenbin Deng; Weimin Dai; Delia M Talos; Leon J Massillon; Paul A Rosenberg; Joseph J Volpe; Frances E Jensen
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

Review 9.  Molecular mechanisms of mTOR-mediated translational control.

Authors:  Xiaoju Max Ma; John Blenis
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04-02       Impact factor: 94.444

Review 10.  Neuropathologic studies of the encephalopathy of prematurity in the late preterm infant.

Authors:  Robin L Haynes; Lynn A Sleeper; Joseph J Volpe; Hannah C Kinney
Journal:  Clin Perinatol       Date:  2013-09-20       Impact factor: 3.430

View more
  3 in total

1.  Exposure to DMSO during infancy alters neurochemistry, social interactions, and brain morphology in long-evans rats.

Authors:  Zachary Rabow; Taryn Morningstar; Megan Showalter; Hailey Heil; Krista Thongphanh; Sili Fan; Joanne Chan; Verónica Martínez-Cerdeño; Robert Berman; David Zagzag; Evgeny Nudler; Oliver Fiehn; Mirna Lechpammer
Journal:  Brain Behav       Date:  2021-04-10       Impact factor: 2.708

Review 2.  Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses.

Authors:  Amirhossein Modabbernia; Eva Velthorst; Abraham Reichenberg
Journal:  Mol Autism       Date:  2017-03-17       Impact factor: 7.509

3.  Protective mechanisms of microRNA-27a against oxygen-glucose deprivation-induced injuries in hippocampal neurons.

Authors:  Qun Cai; Ting Wang; Wen-Jie Yang; Xing Fen
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.